Drug and Market Development Publishing, Oct 2006, Pages: 415
...R), Rituxan(R), Remicade(R), Synagis(R) and Herceptin(R). Humira? was ... Many new alliances involving several antibody and bio/pharmaceutical companies have ...
CanBiotech, Dec 2003, Pages: 33
... Opportunities in Outsourcing Marketing, Regulatory and Downstream Services, This report highlights key issues facing the bio-pharmaceutical industry with regard ...
Research In China, Aug 2009, Pages: 77
... 2 Market Size 3.4.3 R & D 3.5 Other Vaccine Markets and R & D ... Being, 2008 Bird Flu Vaccine Production Capacity of CNADC and Jinyu Baoling Bio-pharmaceutical Co ...
Research In China, Aug 2009, Pages: 77
... 2 Market Size 3.4.3 R & D 3.5 Other Vaccine Markets and R & D ... Being, 2008 Bird Flu Vaccine Production Capacity of CNADC and Jinyu Baoling Bio-pharmaceutical Co ...
Research In China, Jan 2007, Pages: 110
... by the industrial inborn high demands in technology, capital and R & D ... 2 Market Competition 2.2.3 Investment Income and Risks 2.3 Bio-pharmaceutical Industry 2.3 ...
Research In China, Jan 2007, Pages: 110
... by the industrial inborn high demands in technology, capital and R & D ... 2 Market Competition 2.2.3 Investment Income and Risks 2.3 Bio-pharmaceutical Industry 2.3 ...
Bizacumen Inc., Nov 2009, Pages: 302
... Agilent and Picometrics Enter a Non- exclusive Value Added Re -seller Agreement 10 CombiSep Merges with AATI 10 Lonza Acquires Bio-pharmaceutical and Research ...
Global Industry Analysts, Inc., March 2008, Pages: 510
... and Picometrics Enter a Non-exclusive Value Added Re- seller Agreement II-21 CombiSep Merges with AATI II-21 Lonza Acquires Bio-pharmaceutical and Research Bio ...
Bioplan Associates Inc., Nov 2008, Pages: 415
... Benefits: Already, most major large (bio)pharmaceutical companies have made some moves in ... E. coli - prolonged viability MAMMALS 386 CMV/R Promoter - eukaryotes ...
